Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
Torres A, Wible M, Tawadrous M, Irani P, Stone GG, Quintana A, Debabov D, Burroughs M, Bradford PA, Kollef M. Torres A, et al. Among authors: bradford pa. J Antimicrob Chemother. 2023 Nov 6;78(11):2672-2682. doi: 10.1093/jac/dkad280. J Antimicrob Chemother. 2023. PMID: 37700689 Clinical Trial.
New Antimicrobial Agents  …  but No Susceptibility Tests!
Ambler JE, Krause KM, Steenbergen JN, Scangarella-Oman NE, Miller LA, Bhagwat SS, Serio AW, Chesnel L, Mahoney NM, Motyl MR, Critchley IA, Iaconis JP, Stone GG, Alder J, Xerri L, McCurdy SP, van Veenhuyzen DF, Grossman T, Echols RM, Williams G, Bradford PA. Ambler JE, et al. Among authors: bradford pa. Clin Infect Dis. 2016 Dec 1;63(11):1530-1531. doi: 10.1093/cid/ciw603. Epub 2016 Aug 31. Clin Infect Dis. 2016. PMID: 27581762 No abstract available.
In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens.
Stone GG, Bradford PA, Newell P, Wardman A. Stone GG, et al. Among authors: bradford pa. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01820-16. doi: 10.1128/AAC.01820-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27872067 Free PMC article. Clinical Trial.
Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets.
Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK. Mendes RE, et al. Among authors: bradford pa. Antimicrob Agents Chemother. 2017 May 24;61(6):e02447-16. doi: 10.1128/AAC.02447-16. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28348155 Free PMC article. Clinical Trial.
Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK. Mendes RE, et al. Among authors: bradford pa. Int J Antimicrob Agents. 2018 Aug;52(2):287-292. doi: 10.1016/j.ijantimicag.2018.04.001. Epub 2018 Apr 11. Int J Antimicrob Agents. 2018. PMID: 29654893 Clinical Trial.
In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.
Kazmierczak KM, Bradford PA, Stone GG, de Jonge BLM, Sahm DF. Kazmierczak KM, et al. Among authors: bradford pa. Antimicrob Agents Chemother. 2018 Nov 26;62(12):e00592-18. doi: 10.1128/AAC.00592-18. Print 2018 Dec. Antimicrob Agents Chemother. 2018. PMID: 30249690 Free PMC article.
Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers.
Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK. Mendes RE, et al. Among authors: bradford pa. Antimicrob Agents Chemother. 2019 May 24;63(6):e02655-18. doi: 10.1128/AAC.02655-18. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30910899 Free PMC article. Clinical Trial.
121 results